Advantages of routine next-generation sequencing over standard genetic testing in the amyotrophic lateral sclerosis clinic. (2023)

First Author: Scaber J
Attributed to:  Identifying the early biochemical signature of amyotrophic lateral sclerosis funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1111/ene.15855

PubMed Identifier: 37159497

Publication URI: http://europepmc.org/abstract/MED/37159497

Type: Journal Article/Review

Volume: 30

Parent Publication: European journal of neurology

Issue: 8

ISSN: 1351-5101